| __timestamp | Gilead Sciences, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 396000000 |
| Thursday, January 1, 2015 | 3014000000 | 364000000 |
| Friday, January 1, 2016 | 5098000000 | 376000000 |
| Sunday, January 1, 2017 | 3734000000 | 382000000 |
| Monday, January 1, 2018 | 5018000000 | 432000000 |
| Tuesday, January 1, 2019 | 9106000000 | 457000000 |
| Wednesday, January 1, 2020 | 5039000000 | 463000000 |
| Friday, January 1, 2021 | 5363000000 | 508000000 |
| Saturday, January 1, 2022 | 4977000000 | 539000000 |
| Sunday, January 1, 2023 | 6923000000 | 614000000 |
| Monday, January 1, 2024 | 5907000000 | 686000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals and biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Gilead Sciences, Inc. and Zoetis Inc. have been at the forefront of this R&D showdown. From 2014 to 2023, Gilead Sciences has consistently outpaced Zoetis, with its R&D expenses peaking at nearly 7 billion USD in 2023, a staggering 142% increase from 2014. In contrast, Zoetis has shown a steady yet modest growth, with its R&D spending increasing by approximately 55% over the same period. This disparity highlights Gilead's aggressive investment in innovation, potentially positioning it for breakthroughs in treatments and therapies. As the industry continues to evolve, these investments could be pivotal in shaping the future of healthcare.
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Vertex Pharmaceuticals Incorporated
Comparing Innovation Spending: Gilead Sciences, Inc. and BeiGene, Ltd.
Comparing Innovation Spending: Gilead Sciences, Inc. and Regeneron Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.